Phenominer Database Results (15 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Experiment Notes Record ID Study ID
BDIX/Orl body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 84 days 8 206.0 g 3.18 9.0 body weighing method 0.0 0 body weight 106987 3074
BDIX/Orl body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 63 days 4 237.0 g 4.65 9.3 body weighing method 0.0 0 body weight 106991 3074
BDIX/Orl body weight 0.9% sodium chloride solution (1 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 98 days-0 days 2 231.0 g 7.5 10.6 body weighing method 0.0 0 body weight 107011 3074
BDIX/Orl body weight control condition Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 84 days 2 207.0 g 0.0 15.6 body weighing method 0.0 0 body weight 106977 3074
BDIX/Orl body weight 0.9% sodium chloride solution (0.4 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 63 days 2 173.0 g 7.5 10.6 body weighing method 0.0 0 body weight 106981 3074
BDIX/Orl body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 98 days-0 days 4 210.0 g 3.05 6.1 body weighing method 0.0 0 body weight 107005 3074
BDIX/Orl body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 119 days-0 days 8 232.0 g 3.15 8.9 body weighing method 0.0 0 body weight 107002 3074
BDIX/Orl body weight 0.9% sodium chloride solution (0.4 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 63 days 2 233.0 g 26.52 37.5 body weighing method 0.0 0 body weight 106982 3074
BDIX/Orl percentage of study population developing colorectal tumors during a period of time azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. colorectal integrity trait female 224 days-0 days 4 75.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 107020 3074
BDIX/Orl percentage of study population developing colorectal tumors during a period of time azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. colorectal integrity trait male 224 days-0 days 4 75.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 107021 3074
BDIX/Orl body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 63 days 4 180.0 g 2.35 4.7 body weighing method 0.0 0 body weight 106990 3074
BDIX/Orl body weight azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 98 days-0 days 4 361.0 g 8.8 17.6 body weighing method 0.0 0 body weight 107006 3074
BDIX/Orl body weight 0.9% sodium chloride solution (1 ml) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass male 98 days-0 days 2 358.0 g 23.48 33.2 body weighing method 0.0 0 body weight 107012 3074
BDIX/Orl percentage of study population developing colorectal tumors during a period of time azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. colorectal integrity trait female 280 days-0 days 8 75.0 % ex vivo light microscopy with immunohistochemistry 0.0 0 107017 3074
BDIX/Orl body weight control condition Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 119 days-0 days 2 241.0 g 7.99 11.3 body weighing method 0.0 0 body weight 106978 3074